Development of a Molecular Diagnostic Strategy for SARS-CoV2 Based on Saliva in the Context of the COVID-19 Pandemic
NCT04367545
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
130
Enrollment
OTHER
Sponsor class
Conditions
COVID
RT-ddPCR Multiplex
Interventions
DIAGNOSTIC_TEST:
Saliva collection
Sponsor
University Hospital, Rouen